Gerald Mesecher v. HHS - Influenza, Guillain-Barre syndrome (2022)

Gerald Mesecher filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered from Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine administered on October 30, 2019. The respondent conceded that Mr.

Mesecher's claim met the Table criteria for GBS and that he was entitled to compensation. A ruling on entitlement was issued on July 20, 2021, finding Mr.

Mesecher entitled to compensation. Subsequently, on May 5, 2022, the parties filed a proffer on award of compensation.

The respondent recommended an award of $213,246.27 for pain and suffering and past unreimbursable expenses, plus $11,027.21 to satisfy a Medicaid lien, totaling $224,273.48. Mr.

Mesecher agreed with the proffered award. The Chief Special Master issued a decision awarding damages on June 21, 2022, in accordance with the proffer, granting compensation for GBS as a Table injury.